OnKure Therapeutics, Inc.

OKUR · Nasdaq · SIC 2834: Pharmaceutical Preparations
84
SEC Filings

Business Summary

PART I Overview OnKure Therapeutics, Inc. (OnKure, we, us or the Company) is a clinical-stage biopharmaceutical company focused on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases that are underserved by available therapies. Using a structure-based drug design platform, we are committed to improving clinical outcomes for patients by building a pipeline of small molecule drugs designed to achieve optimal efficacy and tol...

Next Earnings

Q2 FY2026 — expected 2026-08-14

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionOKURdiscussed_in_filing Cybersecurity
topic_mentionOKURdiscussed_in_filing Cybersecurity
topic_mentionOKURdiscussed_in_filing Healthcare & Bio
topic_mentionOKURdiscussed_in_filing Platform & Ecosystem
topic_mentionOKURdiscussed_in_filing Healthcare & Bio
topic_mentionOKURdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-122025-12-310001193125-26-104147EDGAR103K words
2025-03-102024-12-310000950170-25-036252EDGAR—
2024-03-282023-12-310000950170-24-038009EDGAR—
2023-03-272022-12-310000950170-23-009978EDGAR—
2022-03-232021-12-310001558370-22-004158EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-269540EDGAR60K words
2025-08-122025-06-300001193125-25-178981EDGAR—
2025-05-062025-03-310000950170-25-063970EDGAR—
2024-11-072024-09-300000950170-24-123233EDGAR—
2024-08-132024-06-300000950170-24-096411EDGAR—
2024-05-072024-03-310000950170-24-054452EDGAR—
2023-11-132023-09-300000950170-23-062910EDGAR—
2023-08-102023-06-300000950170-23-041302EDGAR—
2023-05-112023-03-310000950170-23-021234EDGAR—
2022-11-082022-09-300000950170-22-023250EDGAR—
2022-08-092022-06-300000950170-22-016035EDGAR—
2022-05-102022-03-310001558370-22-008103EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001193125-26-130283EDGAR20K words
2026-03-120001193125-26-104104EDGAR—
2025-11-060001193125-25-269652EDGAR—
2025-11-060001193125-25-269468EDGAR—
2025-08-120001193125-25-178978EDGAR—
2025-06-260000950170-25-090403EDGAR—
2025-05-280000950170-25-078375EDGAR—
2025-05-060000950170-25-063969EDGAR—
2025-03-100000950170-25-036306EDGAR—
2024-12-100000950170-24-134757EDGAR—

84 total filings indexed. 57 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001637715
TickerOKUR
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: b9ea872231ea21620636ddd375c9cc5d3c434217c8705dd58102b3504f61d93d
parent: fcf6f7b97fe67414755bef97a6f1ed7fb8fb8fcc67ac00954777c5563a014a7c
content hash: e4458e601c514e5621c4084ff29455b23e765751c76f4559385bafb1e6201e57
signed: 2026-04-13T04:46:42.532Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf